Product Related. Within five (5) Business Days of receipt, copies of all material correspondence, reports, documents and other filings with any Governmental Authority that could reasonably be expected to have a material adverse effect on any Governmental Approvals required for the manufacturing, marketing, testing or sale of Products or which could have a Material Adverse Effect.

Product Related. Within five Business Days of receipt, copies of all material correspondence, reports, documents and other filings with any Governmental Authority that could reasonably be expected to have a material adverse effect on any Governmental Approvals required for the manufacturing, marketing, testing or sale of Products or which could have a Material Adverse Effect.

Product Related. Within three (3) Business Days of receipt, copies of all material correspondence, reports, documents and other filings with any Governmental Authority that could reasonably be expected to have a material adverse effect on any Governmental Approvals required for the manufacturing, marketing, testing or sale of Products or which could reasonably be expected to have a Material Adverse Effect.

Product-related Indemnification. Additionally, each Party will defend, indemnify, and hold harmless the other Party (and any other indemnitees expressly provided in the Standard Terms) for Claims and Losses relating to the purchase, manufacture, and use of IVD Hardware and [[Illumina:Organization]] Components purchased by Partner from [[Illumina:Organization]] under this Agreement if and to the extent, and subject to all terms and conditions, provided in the Standard Terms. For clarity, [[Illumina:Organization]]’s defense, indemnification, and hold harmless obligations with respect to the [[Illumina:Organization]] Components and IVD Hardware, and Partner’s and its Customers’ purchase and use of such products, are limited solely to those obligations expressly provided in the Standard Terms for such products.

Complaints Related to the Product. Apellis will use Commercially Reasonable Efforts to investigate and resolve complaints that it receives related to the Product.

Product. ​ as further detailed in the Project Plan attached to this Project [Appendix 1].

“Product”. Product means any pharmaceutical preparation containing one or more Compounds as its only active ingredient(s) or any Combination Product. In any Region, a Product shall be considered a separate Product from other Products to the extent that it requires a separate Regulatory Approval.

Product-Related Regulatory Interactions. From and after the end of the Research Term, as between the Parties, Lilly shall be solely responsible for any communications with any Regulatory Authorities regarding the Products. In the event that Aduro receives any communication from a Regulatory Authority following the end of the Research Term, Aduro shall refer such Regulatory Authority to Lilly ​.

“Product”. Product means any pharmaceutical preparation containing one or more Compounds as its only active ingredient(s) or any Combination Product.

Product. The Product shall not be adulterated or misbranded as provided in the Food, Drug and Cosmetic Act, as amended from time to time;